Published in Vaccine Weekly, August 30th, 1999
Kim D. Janda, PhD, The Scripps Research Institute, La Jolla, California, said he has induced the immune system to create specific antibodies that attack the cocaine molecule and keep it from reaching its target - the central nervous system.
Cocaine does not produce antibodies because its molecule is too small to be recognized by the immune system. Janda said he has overcome this obstacle by attaching a cocaine derivative to a larger protein - an effect he calls...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1999-08-30)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.